HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 80.9%

Neg 0% Neu 80.9% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and maintains $10 price target.